China SXT Pharmaceuticals (SXTC) Current Assets (2018 - 2025)
Historic Current Assets for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $26.0 million.
- China SXT Pharmaceuticals' Current Assets rose 1843.74% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 1843.74%. This contributed to the annual value of $21.3 million for FY2025, which is 4962.38% up from last year.
- According to the latest figures from Q3 2025, China SXT Pharmaceuticals' Current Assets is $26.0 million, which was up 1843.74% from $21.3 million recorded in Q1 2025.
- China SXT Pharmaceuticals' 5-year Current Assets high stood at $26.0 million for Q3 2025, and its period low was $11.7 million during Q3 2021.
- In the last 5 years, China SXT Pharmaceuticals' Current Assets had a median value of $20.4 million in 2023 and averaged $18.6 million.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Current Assets tumbled by 4713.65% in 2021, and later surged by 6293.29% in 2024.
- Over the past 5 years, China SXT Pharmaceuticals' Current Assets (Quarter) stood at $11.7 million in 2021, then rose by 5.99% to $12.4 million in 2022, then grew by 9.19% to $13.5 million in 2023, then soared by 62.93% to $22.0 million in 2024, then increased by 18.44% to $26.0 million in 2025.
- Its Current Assets was $26.0 million in Q3 2025, compared to $21.3 million in Q1 2025 and $22.0 million in Q3 2024.